4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004234
Options or other derivatives
- PRESIDENT AND CEO acquired 164,380 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Torley Helen PRESIDENT AND CEO | 2025-02-12 | Grant or award · Performance Stock Units | +24,957 | 71,810 | D | ||
| Torley Helen PRESIDENT AND CEO | 2025-02-12 | Grant or award · Performance Stock Units | +20,008 | 31,364 | D | ||
| Torley Helen PRESIDENT AND CEO | 2025-02-12 | Grant or award · Performance Stock Unit | +23,260 | 23,260 | D | ||
| Torley Helen PRESIDENT AND CEO | 2025-02-12 | Grant or award · Performance Stock Units | +96,155 | 96,155 | D | ||
Loading xslF345X05/form4-02142025_110239.xml…